濮阳东方男科口碑好吗(濮阳东方医院治阳痿非常好) (今日更新中)

SEATTLE (AP) — The NHL's newest team finally has its name: the Seattle Kraken. The expansion franchise unveiled its nickname Thursday, ending 19 months of speculation about whether the team might lean traditional or go eccentric with the name for the league's 32nd team. 279

SAN YSIDRO, Calif. (KGTV) -- Firefighters were able to knock down a two acre brush fire in San Ysidro Sunday morning. According to San Diego Fire Rescue, the fire sparked just before 7:20 a.m. in a rural canyon east of San Ysidro. The department says, due to the difficult terrain, crews had to be flown in to fight the blaze. RELATED: San Diegans urged to prepare for wildfiresSan Diego Fire-Rescue says the fire burned approximately two acres. The cause of the blaze is unknown at this time, but the Metro Arson Strike Team has been called in to investigate. 569

SEATTLE (AP) — Cookware and kitchen chain Sur La Table is closing 56 of its 121 stores as it seeks bankruptcy protection, the latest retail casualty of the coronavirus pandemic. The privately-held Seattle-based company says it has agreed to sell its remaining stores to affiliates of Fortress Investment Group following the bankruptcy procedure and store closures. “This sale process will result in a revitalized Sur La Table, positioned to thrive in a post-COVID-19 retail environment," CEO Jason Goldberger said in the press release. "Sur La Table will have a balance sheet and retail footprint optimized to position the Company for a bright future that continues our nearly 50-year tradition of offering high-quality cooking products and experiences to our customers.”The post-sale company will also include its in-person and online cooking classes and its e-commerce business. Sur La's chefs typically teach 60,000 cooking classes a year to more than 700,000 people, the company said.Sur La Table had its start in Seattle's Pike Place Market in 1972. 1062

SEATTLE (AP) — Prosecutors plan to decide on charges against the man who hit two protesters with his car while driving on a Seattle freeway that was closed for Black Lives Matter demonstrations. One of the protesters was killed. Police say Dawit Kelete hit two people at about 1:40 a.m. Saturday. Summer Taylor, a 24-year-old veterinary clinic worker, suffered critical injuries and died Saturday night. Diaz Love was hospitalized in serious condition. The King County prosecutor's office said it was reviewing investigation documents and would decide on charges by Wednesday afternoon. The driver is being held on a .2 million bail. 643

Scientists, doctors and the public are eagerly waiting to hear how effective a COVID-19 vaccine will be and how soon it could be available to everyone. But when the vaccine is ready, some will be racing to be first in line, while others will be cautiously waiting to see how it plays out."Only about half of people get a flu vaccination polls are showing. In terms of the coronavirus, that’s saying that a third to maybe as much as half of the population will not want to get a vaccine," said Arthur Evans, the CEO of the American Psychological Association.Evans is concerned about whether people will be willing to get the COVID-19 vaccine when it comes out. How people are educated about the upcoming vaccine will be crucial."Right now, I think there are a lot of people who want to take a vaccine and to get a vaccine, but if people feel that this has been rushed, that they don’t feel all of the normal safety measures have been taken, it's going to be much harder for people to take that step," explained Evans.Dr. Bali Pulendran, a pathology, microbiology and immunology professor at Stanford University, says just because a COVID-19 vaccine is being expedited doesn't mean it's any less safe."It's a very established, lengthy process. It’s expedited now because of certain technologies such as the mRNA technology that really helps you accelerate this process," said Dr. Pulendran.He says the creation of a vaccine is rigorously tested, first with mice, then primates, and finally, humans. Tens of thousands of people are currently choosing to participate in COVID-19 vaccine trials."And so, this is a development and paradigm that has served vaccinology really well. It's really served it well in terms of enabling the licensure of some 20 or more vaccines," said Dr. Pulendran.Dr. Pulendran says every year, the flu vaccine varies in efficacy. For a good year, it could be 90 percent protective, while the next year, the flu shot may only be 10 percent effective. The COVID-19 vaccine is expected to be 60 percent effective."I think for me, personally, if I saw a vaccine coming out in the next year or so that had a 60 to 70 percent efficacy, that to me would be very encouraging," said Dr. Pulendran.The public, though, may still need some convincing."One of the hardest things for the general public to embrace is the idea of probability. We like to know definitively if something works or not,” said Evans. “The reality is that a vaccine is a probabilistic issue. It's highly likely that you won’t contract, whatever the condition is, but it’s not 100 percent."Evans says the key will be in how the vaccine is marketed to the American public.Dr. Pulendran hopes any positive data and outcomes of the COVID-19 vaccine trial will encourage as many people as possible to get the vaccine when it comes out. 2823

来源：资阳报